Table 3.
Indications | Positive endoscopic yield |
Negative endoscopic yield |
Total | ||
---|---|---|---|---|---|
n | % | n | % | ||
Variceal surviellance/Eradication | |||||
Suspected CLD | 32 | 34.8 | 60 | 65.2 | 92 |
EHPVO | 37 | 82.2 | 8 | 17.8 | 45 |
Check EGD | 17 | 85 | 3 | 15 | 20 |
Dyspepsia | 54 | 37.8 | 89 | 62.2 | 143 |
UGI bleeding | 97 | 71.3 | 39 | 28.7 | 136 |
Abdominal pain | 34 | 36.2 | 60 | 63.8 | 94 |
Anemia | 17 | 23.0 | 57 | 77.0 | 74 |
Vomiting | 19 | 38.0 | 31 | 62.0 | 50 |
GERD | 12 | 35.3 | 22 | 64.7 | 34 |
MAS | 6 | 21.4 | 22 | 78.6 | 28 |
Biliary ascariasis | 9 | 52.9 | 8 | 47.1 | 17 |
Dysphagia | 5 | 29.4 | 12 | 70.6 | 17 |
Acute pancreatitis | 2 | 20 | 8 | 80 | 10 |
Corrosive injury | 8 | 80.0 | 2 | 20.0 | 10 |
Hematochezia | 3 | 30.0 | 7 | 70.0 | 10 |
Others | 24 | 57.1 | 18 | 42.9 | 42 |
Total | 376 | 45.8 | 446 | 54.3 | 822 |
CLD, chronic liver disease; EGD, esophagogastroduodenoscopy; EHPVO, extrahepatic portal venous obstruction; GERD, gastroesophageal reflux disease; MAS, malabsorption syndrome; UGI, upper gastrointestinal.